ArticleAnnals of surgical oncology2025
Extended Left Hepatectomy with Inferior Vena Cava Replacement and Right Hepatic Vein Re-implantation Under In Situ Cooling and Venous Bypass for Advanced Intrahepatic Cholangiocarcinoma: H123458-RHV-IVC.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Reply to: "Futility in the Era of R1 Vascular Resection: Friend or Foe When the Endpoint is Overall Survival?"Annals of surgical oncology · 2026Article
- ASO Author Reflections: Locally Advanced Intrahepatic Cholangiocarcinoma: Is R1 Resection by Necessity Justified?Annals of surgical oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundResection of intrahepatic cholangiocarcinoma (iCCA) with invasion of major venous structures is controversial because of its significant morbidity and mortality and questionable oncological value.
resultsThe procedure began with liver mobilization, hilar dissection, and lymphadectomy. Total vascular exclusion (TVE) was required and an elective venous bypass was created using the femoral and inferior mesenteric veins to the axillary vein. TVE was placed, and liver cooling was performed using 3 L of IGL solution delivered through the left portal vein stump, vented by an opening in the IVC. An extended left hepatectomy with en bloc resection of the retrohepatic IVC and main hepatic veins was performed. At the end of the transection, tumor contact was confirmed at the distal end of the RHV, resulting in an R1 vascular resection. A posterior patch of the RHV, including three constitutive branches, was kept for reconstruction. The IVC was replaced with a 16 Fr polytetrafluoroethylene (PTFE) graft, and an RHV patch was re-implanted on the side of the PTFE graft. The duration of both the surgery and the venous bypass was 560 and 130 min, respectively. The patient developed transient postoperative hepatic failure and was discharged on day 18. The pathology results indicated pT3N0 stage with a focal R1 margin, as seen during surgery. The patient declined adjuvant treatment. Eight years after surgery, the patient is alive and disease-free, with excellent quality of life.
conclusionsExtreme surgical approaches can allow for long-term survival and possible cure in selected patients with advanced iCCA. Focal R1 resection may occur in such instances and should be considered on a case-by-case decision.
Indexed as
Identifiers
40254657What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.